论文部分内容阅读
国家医药管理局最近发出紧急通知,要求在全行业开展查处假劣医药产品活动。 《通知》指出:据湖南、四川、广东、吉林、江苏、江西、海南等地反映,近来假冒伪劣药品和一次性输液器在一些地区和医药工商企业沉渣泛起,有的已进入医药主渠道。为确保人民群众用药安全有效,我局决定立即在医药行业开展严厉查处假冒伪劣医药产品的活动。具体要求如下: 1.各医药工商企业立即组织人员对本企业生产、经营的产品进行自查,发现假冒伪劣产品应立即封存并上报医药管理部
The State Medical Administration recently issued an urgent circular calling for the investigation and punishment of counterfeit pharmaceutical products in the entire industry. According to the “Notice”, Hunan, Sichuan, Guangdong, Jilin, Jiangsu, Jiangxi and Hainan reflect the recent emergence of counterfeit medicines and disposable infusions in sediments in some areas and pharmaceutical industrial and commercial enterprises. Some have entered the main channel of medicine . In order to ensure the safety and effectiveness of drug use by the people, our bureau has decided to immediately launch a vigorous investigation and prosecution of counterfeit and inferior medical products in the pharmaceutical industry. The specific requirements are as follows: 1. All medical and industrial and commercial enterprises immediately organize personnel to conduct self-examination on the products they produce and manage, and find that counterfeit and shoddy products should be immediately sealed and reported to the Department of Pharmaceutical Administration